VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,386,629 | +8.0% | 46,815 | +5.8% | 0.02% | +15.4% |
Q2 2023 | $2,209,945 | +70.4% | 44,252 | +27.8% | 0.01% | +44.4% |
Q1 2023 | $1,297,295 | -20.2% | 34,613 | +2.0% | 0.01% | -18.2% |
Q4 2022 | $1,626,656 | +164.9% | 33,924 | +32.7% | 0.01% | +175.0% |
Q3 2022 | $614,000 | +14.3% | 25,571 | +3.6% | 0.00% | 0.0% |
Q2 2022 | $537,000 | +5.1% | 24,672 | +16.5% | 0.00% | +33.3% |
Q1 2022 | $511,000 | 0.0% | 21,170 | -1.4% | 0.00% | 0.0% |
Q4 2021 | $511,000 | -8.9% | 21,467 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $561,000 | +12.0% | 22,110 | -0.7% | 0.00% | +50.0% |
Q2 2021 | $501,000 | +50.5% | 22,272 | +31.9% | 0.00% | +100.0% |
Q1 2021 | $333,000 | +18.5% | 16,885 | +59.5% | 0.00% | 0.0% |
Q4 2020 | $281,000 | -47.8% | 10,586 | -2.8% | 0.00% | -66.7% |
Q3 2020 | $538,000 | – | 10,889 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,457,300 | $54,619,604 | 23.40% |
Pivotal bioVenture Partners Investment Advisor LLC | 693,039 | $25,975,102 | 10.70% |
RA Capital Management | 7,291,254 | $273,276,200 | 6.19% |
Kynam Capital Management, LP | 1,216,784 | $45,605,064 | 5.89% |
GREAT POINT PARTNERS LLC | 659,211 | $24,707,228 | 4.85% |
Frazier Life Sciences Management, L.P. | 1,397,405 | $52,374,739 | 3.79% |
ACUTA CAPITAL PARTNERS, LLC | 120,500 | $4,516,340 | 3.33% |
Ghost Tree Capital, LLC | 225,000 | $8,433,000 | 2.49% |
Carlyle Group Inc. | 1,923,158 | $72,079,962 | 2.15% |
Opaleye Management Inc. | 177,000 | $6,633,960 | 1.99% |